Now showing items 1-3 of 3

    • B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity. 

      Yi, John S; Russo, Melissa A; Massey, Janice M; Juel, Vern; Hobson-Webb, Lisa D; Gable, Karissa; Raja, Shruti M; ... (10 authors) (Front Neurol, 2017)
      Myasthenia gravis (MG) is a T cell-dependent, B cell-mediated disease. The mechanisms for loss of self-tolerance in this disease are not well understood, and recently described regulatory B cell (Breg) subsets have not been ...
    • Characterization of B cells in muscle-specific kinase antibody myasthenia gravis. 

      Guptill, Jeffrey T; Yi, John S; Sanders, Donald B; Guidon, Amanda C; Juel, Vern C; Massey, Janice M; Howard, James F; ... (11 authors) (Neurol Neuroimmunol Neuroinflamm, 2015-04)
      OBJECTIVE: To characterize B-cell subsets in patients with muscle-specific tyrosine kinase (MuSK) myasthenia gravis (MG). METHODS: In accordance with Human Immunology Project Consortium guidelines, we performed polychromatic ...
    • Myasthenia gravis. 

      Juel, Vern C; Massey, Janice M (Orphanet J Rare Dis, 2007-11-06)
      Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups. Ocular ...